Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 04 April, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Religare Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 4, 2025, 11:04 am

Market Cap 7,417 Cr.
Current Price 224
High / Low 320/201
Stock P/E253
Book Value 74.1
Dividend Yield0.00 %
ROCE9.24 %
ROE5.32 %
Face Value 10.0
PEG Ratio2.79

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Religare Enterprises Ltd

Competitors of Religare Enterprises Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
MKVentures Capital Ltd 567 Cr. 1,474 2,800/1,21227.5 2670.07 %20.6 %33.6 % 10.0
Modern Shares & Stockbrokers Ltd 14.6 Cr. 49.8 69.4/36.041.7 43.90.00 %4.33 %3.24 % 10.0
Monarch Networth Capital Ltd 2,644 Cr. 337 501/22617.0 93.00.15 %51.8 %43.4 % 10.0
Monotype India Ltd 51.3 Cr. 0.73 2.42/0.606.42 0.130.00 %438 %% 1.00
Multipurpose Trading & Agencies Ltd 5.10 Cr. 10.3 13.3/7.9326.8 10.20.00 %4.44 %3.91 % 10.0
Industry Average6,624.63 Cr1,391.1886.685,208.090.37%18.65%17.36%7.36

All Competitor Stocks of Religare Enterprises Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 8279539511,1641,1651,3961,2851,5841,5111,8561,7101,9521,664
Expenses 9218249231,1171,0201,1491,1471,4831,4551,8331,6531,8761,730
Operating Profit -94128284714524713810156235776-66
OPM % -11%13%3%4%12%18%11%6%4%1%3%4%-4%
Other Income 5431011933,354181272495196
Interest 197181189197213292625241813135
Depreciation 14141413141419181817161514
Profit before tax -250-63-75-144-793,55711259412363367-79
Tax % 0%826%1%22%22%1%17%32%18%23%18%-2%-20%
Net Profit -251-588-76-177-963,5179340341812768-63
EPS in Rs -7.84-19.20-2.38-6.49-3.62107.611.940.780.593.800.551.55-1.30

Last Updated: February 28, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Religare Enterprises Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹1,664.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,952.00 Cr. (Sep 2024) to ₹1,664.00 Cr., marking a decrease of 288.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹1,730.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,876.00 Cr. (Sep 2024) to ₹1,730.00 Cr., marking a decrease of 146.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹-66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Sep 2024) to ₹-66.00 Cr., marking a decrease of 142.00 Cr..
  • For OPM %, as of Dec 2024, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 4.00% (Sep 2024) to -4.00%, marking a decrease of 8.00%.
  • For Other Income, as of Dec 2024, the value is ₹6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to ₹6.00 Cr., marking a decrease of 13.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Sep 2024) to ₹5.00 Cr., marking a decrease of 8.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Sep 2024) to ₹14.00 Cr., marking a decrease of 1.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹-79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2024) to ₹-79.00 Cr., marking a decrease of 146.00 Cr..
  • For Tax %, as of Dec 2024, the value is -20.00%. The value appears to be improving (decreasing) as expected. It has decreased from -2.00% (Sep 2024) to -20.00%, marking a decrease of 18.00%.
  • For Net Profit, as of Dec 2024, the value is ₹-63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Sep 2024) to ₹-63.00 Cr., marking a decrease of 131.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is -1.30. The value appears to be declining and may need further review. It has decreased from 1.55 (Sep 2024) to -1.30, marking a decrease of 2.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 7:02 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 3,7623,3614,1284,8953,7092,6752,3712,3842,5133,2274,6796,2667,182
Expenses 1,4601,5852,0063,7101,6592,8413,0052,3412,2353,5924,1965,8987,091
Operating Profit 2,3021,7752,1221,1842,050-167-63443278-36448336890
OPM % 61%53%51%24%55%-6%-27%2%11%-11%10%6%1%
Other Income -77725581,012-3166010-157171373,473263279
Interest 1,7221,5841,6581,8791,8401,27185485573375064111250
Depreciation 60343736313026615953567262
Profit before tax -258182485282-136-1,407-1,504-1,030-497-1,0313,259448258
Tax % 87%85%34%79%-10%-16%-0%1%-4%49%3%22%
Net Profit -4812732161-124-1,181-1,501-1,038-478-1,5393,169347213
EPS in Rs -37.09-4.638.62-2.67-9.77-58.56-59.33-36.12-19.60-48.4395.247.064.60
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)105.61%1088.89%-81.00%-303.28%-852.42%-27.10%30.85%53.95%-221.97%305.91%-89.05%
Change in YoY Net Profit Growth (%)0.00%983.28%-1169.89%-222.28%-549.14%825.32%57.94%23.10%-275.92%527.88%-394.96%

Religare Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:6%
5 Years:21%
3 Years:36%
TTM:24%
Compounded Profit Growth
10 Years:11%
5 Years:16%
3 Years:31%
TTM:-92%
Stock Price CAGR
10 Years:-4%
5 Years:61%
3 Years:19%
1 Year:1%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:5%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:52 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 149150178178178178217258259319324330330
Reserves 2,9702,9823,7053,6602,5491,658616-157-306-1,3011,7342,0132,121
Borrowings 13,42114,07316,49120,24714,9569,9456,7175,3564,9404,878841443206
Other Liabilities 3,7553,9205,0643,3443,3552,0812,0232,6733,8325,4675,1936,7897,620
Total Liabilities 20,29521,12525,43927,42921,03813,8629,5738,1308,7259,3628,0929,57510,276
Fixed Assets 1,8221,9812,1281,7851038083175117127196161157
CWIP 4124412111413122560
Investments 2,4193,3444,3632,7001,9831,1971,4382,0233,1903,8365,0946,7187,584
Other Assets 16,04915,78818,94422,94118,94012,5748,0385,9195,4065,3972,7972,6902,536
Total Assets 20,29521,12525,43927,42921,03813,8629,5738,1308,7259,3628,0929,57510,276

Below is a detailed analysis of the balance sheet data for Religare Enterprises Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹330.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 330.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹2,121.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,013.00 Cr. (Mar 2024) to ₹2,121.00 Cr., marking an increase of 108.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹206.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 443.00 Cr. (Mar 2024) to ₹206.00 Cr., marking a decrease of 237.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹7,620.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,789.00 Cr. (Mar 2024) to ₹7,620.00 Cr., marking an increase of 831.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹10,276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,575.00 Cr. (Mar 2024) to ₹10,276.00 Cr., marking an increase of 701.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2024) to ₹157.00 Cr., marking a decrease of 4.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 6.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹7,584.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,718.00 Cr. (Mar 2024) to ₹7,584.00 Cr., marking an increase of 866.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹2,536.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,690.00 Cr. (Mar 2024) to ₹2,536.00 Cr., marking a decrease of 154.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹10,276.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,575.00 Cr. (Mar 2024) to ₹10,276.00 Cr., marking an increase of 701.00 Cr..

Notably, the Reserves (2,121.00 Cr.) exceed the Borrowings (206.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +2,9361,634-706-2,1545,8715,8023,5552,4331,3731,5961,5061,500
Cash from Investing Activity +-730-403-6124992,149-457-31-436-1,181-689-939-1,348
Cash from Financing Activity +-2,326-1,4001,0941,853-7,696-6,455-3,819-1,743-314559-2,079-156
Net Cash Flow-120-169-224198324-1,110-295254-1221,466-1,512-4

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-11.00-13.00-14.00-19.00-12.00-176.00-640.0038.00274.00-368.00-358.00-75.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days475252356042531428211414
Inventory Days
Days Payable
Cash Conversion Cycle475252356042531428211414
Working Capital Days265104564226-118-98-267-264-387-275-291
ROCE %11%11%11%9%10%-1%-7%-0%4%-6%16%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
FIIs19.59%18.99%19.60%18.79%18.30%19.48%11.75%9.89%7.91%8.49%8.01%8.05%
DIIs2.38%3.82%5.63%7.18%7.42%7.00%7.84%7.75%8.17%10.99%13.43%13.14%
Public78.03%77.19%74.77%74.02%74.27%73.52%80.41%82.36%83.92%80.51%78.56%78.82%
No. of Shareholders57,18955,61355,22259,75259,29257,93961,53569,31184,52783,05079,94680,236

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal Large and Midcap Fund3,000,0002.4867.582,022,2992025-04-0348.35%
Motilal Oswal ELSS Tax Saver Fund2,900,0002.3765.322,022,2992025-04-0343.4%
Motilal Oswal Balance Advantage Fund2,740,7287.461.732,022,2992025-04-0335.53%
Motilal Oswal Focused Fund2,022,2992.5645.552,022,2992025-04-030%
Motilal Oswal Equity Hybrid Fund894,3034.720.142,022,2992025-04-03-55.78%
Motilal Oswal Nifty Microcap 250 Index Fund340,5981.347.672,022,2992025-04-03-83.16%
Motilal Oswal Multi Asset Fund250,0005.125.632,022,2992025-04-03-87.64%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 7.1396.06-51.33-19.65-39.55
Diluted EPS (Rs.) 7.0794.67-51.33-19.65-39.62
Cash EPS (Rs.) 12.7199.67-46.58-16.15-37.85
Book Value[Excl.RevalReserv]/Share (Rs.) 96.2882.75-16.6911.487.53
Book Value[Incl.RevalReserv]/Share (Rs.) 96.2882.75-16.6911.487.53
Revenue From Operations / Share (Rs.) 189.09144.53101.1195.8691.25
PBDIT / Share (Rs.) 11.6020.20-7.4611.041.94
PBIT / Share (Rs.) 9.4318.46-9.148.77-0.41
PBT / Share (Rs.) 13.58100.71-32.34-19.17-39.90
Net Profit / Share (Rs.) 10.5497.93-48.26-18.41-40.21
NP After MI And SOA / Share (Rs.) 3.4795.24-48.43-19.60-36.12
PBDIT Margin (%) 6.1313.97-7.3811.512.12
PBIT Margin (%) 4.9812.77-9.039.15-0.45
PBT Margin (%) 7.1869.68-31.98-20.00-43.72
Net Profit Margin (%) 5.5767.75-47.72-19.21-44.06
NP After MI And SOA Margin (%) 1.8365.89-47.89-20.44-39.58
Return on Networth / Equity (%) 4.88149.760.000.00-923.09
Return on Capital Employeed (%) 4.5610.92-19.5410.06-0.61
Return On Assets (%) 1.1938.07-16.50-5.82-11.46
Long Term Debt / Equity (X) 0.000.000.00-11.925.59
Total Debt / Equity (X) 0.140.35-4.92-103.8553.02
Asset Turnover Ratio (%) 0.700.000.000.000.00
Current Ratio (X) 3.252.811.111.161.08
Quick Ratio (X) 3.252.811.111.161.08
Interest Coverage Ratio (X) 4.091.04-0.320.390.05
Interest Coverage Ratio (Post Tax) (X) 2.250.80-1.080.34-0.02
Enterprise Value (Cr.) 7005.915230.887032.765988.224485.50
EV / Net Operating Revenue (X) 1.121.122.182.411.90
EV / EBITDA (X) 18.318.01-29.5520.9189.49
MarketCap / Net Operating Revenue (X) 1.111.001.290.910.20
Price / BV (X) 2.952.28-4.22-48.264.86
Price / Net Operating Revenue (X) 1.111.001.290.910.20
EarningsYield 0.010.65-0.37-0.22-1.90

After reviewing the key financial ratios for Religare Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 7.13. This value is within the healthy range. It has decreased from 96.06 (Mar 23) to 7.13, marking a decrease of 88.93.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 7.07. This value is within the healthy range. It has decreased from 94.67 (Mar 23) to 7.07, marking a decrease of 87.60.
  • For Cash EPS (Rs.), as of Mar 24, the value is 12.71. This value is within the healthy range. It has decreased from 99.67 (Mar 23) to 12.71, marking a decrease of 86.96.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 96.28. It has increased from 82.75 (Mar 23) to 96.28, marking an increase of 13.53.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 96.28. It has increased from 82.75 (Mar 23) to 96.28, marking an increase of 13.53.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 189.09. It has increased from 144.53 (Mar 23) to 189.09, marking an increase of 44.56.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 11.60. This value is within the healthy range. It has decreased from 20.20 (Mar 23) to 11.60, marking a decrease of 8.60.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 9.43. This value is within the healthy range. It has decreased from 18.46 (Mar 23) to 9.43, marking a decrease of 9.03.
  • For PBT / Share (Rs.), as of Mar 24, the value is 13.58. This value is within the healthy range. It has decreased from 100.71 (Mar 23) to 13.58, marking a decrease of 87.13.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 10.54. This value is within the healthy range. It has decreased from 97.93 (Mar 23) to 10.54, marking a decrease of 87.39.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.47. This value is within the healthy range. It has decreased from 95.24 (Mar 23) to 3.47, marking a decrease of 91.77.
  • For PBDIT Margin (%), as of Mar 24, the value is 6.13. This value is below the healthy minimum of 10. It has decreased from 13.97 (Mar 23) to 6.13, marking a decrease of 7.84.
  • For PBIT Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 10. It has decreased from 12.77 (Mar 23) to 4.98, marking a decrease of 7.79.
  • For PBT Margin (%), as of Mar 24, the value is 7.18. This value is below the healthy minimum of 10. It has decreased from 69.68 (Mar 23) to 7.18, marking a decrease of 62.50.
  • For Net Profit Margin (%), as of Mar 24, the value is 5.57. This value is within the healthy range. It has decreased from 67.75 (Mar 23) to 5.57, marking a decrease of 62.18.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.83. This value is below the healthy minimum of 8. It has decreased from 65.89 (Mar 23) to 1.83, marking a decrease of 64.06.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 4.88. This value is below the healthy minimum of 15. It has decreased from 149.76 (Mar 23) to 4.88, marking a decrease of 144.88.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 4.56. This value is below the healthy minimum of 10. It has decreased from 10.92 (Mar 23) to 4.56, marking a decrease of 6.36.
  • For Return On Assets (%), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 5. It has decreased from 38.07 (Mar 23) to 1.19, marking a decrease of 36.88.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has decreased from 0.35 (Mar 23) to 0.14, marking a decrease of 0.21.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has increased from 0.00 (Mar 23) to 0.70, marking an increase of 0.70.
  • For Current Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 23) to 3.25, marking an increase of 0.44.
  • For Quick Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 2. It has increased from 2.81 (Mar 23) to 3.25, marking an increase of 0.44.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 4.09. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 4.09, marking an increase of 3.05.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.25. This value is below the healthy minimum of 3. It has increased from 0.80 (Mar 23) to 2.25, marking an increase of 1.45.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 7,005.91. It has increased from 5,230.88 (Mar 23) to 7,005.91, marking an increase of 1,775.03.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.12.
  • For EV / EBITDA (X), as of Mar 24, the value is 18.31. This value exceeds the healthy maximum of 15. It has increased from 8.01 (Mar 23) to 18.31, marking an increase of 10.30.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.11. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 1.11, marking an increase of 0.11.
  • For Price / BV (X), as of Mar 24, the value is 2.95. This value is within the healthy range. It has increased from 2.28 (Mar 23) to 2.95, marking an increase of 0.67.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.11. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 1.11, marking an increase of 0.11.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.65 (Mar 23) to 0.01, marking a decrease of 0.64.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Religare Enterprises Ltd as of April 4, 2025 is: 813.84

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 4, 2025, Religare Enterprises Ltd is Undervalued by 263.32% compared to the current share price 224.00

Intrinsic Value of Religare Enterprises Ltd as of April 4, 2025 is: 1,551.74

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 4, 2025, Religare Enterprises Ltd is Undervalued by 592.74% compared to the current share price 224.00

Last 5 Year EPS CAGR: 90.67%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -100.58, which is a positive sign.
  2. The company has shown consistent growth in sales (3.46 cr) and profit (58.69 cr) over the years.
  1. The stock has a low average ROCE of 5.58%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 36.00, which may not be favorable.
  3. The company has higher borrowings (8,654.92) compared to reserves (1,711.08), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Religare Enterprises Ltd:
    1. Net Profit Margin: 5.57%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 4.56% (Industry Average ROCE: 18.65%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 4.88% (Industry Average ROE: 17.36%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.25
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.25
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 253 (Industry average Stock P/E: 86.68)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.14
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Religare Enterprises Ltd. is a Public Limited Listed company incorporated on 30/01/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1984PLC146935 and registration number is 146935. Currently Company is involved in the business activities of Activities of holding companies. Company's Total Operating Revenue is Rs. 11.78 Cr. and Equity Capital is Rs. 329.72 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Finance & Investments1407, 14th Floor, Chiranjiv Tower, New Delhi Delhi 110019investorservices@religare.com
http://www.religare.com
Management
NamePosition Held
Dr. Rashmi SalujaExecutive Chairperson
Mr. Hamid AhmedIndependent Director
Mr. Praveen Kumar TripathiIndependent Director
Mr. Malay Kumar SinhaIndependent Director
Mr. Ranjan DwivediIndependent Director
Mrs. Preeti MadanIndependent Director

FAQ

What is the intrinsic value of Religare Enterprises Ltd?

Religare Enterprises Ltd's intrinsic value (as of 04 April 2025) is ₹813.84 — 263.32% higher the current market price of ₹224.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 7,417 Cr. market cap, FY2025-2026 high/low of ₹320/201, reserves of 2,121 Cr, and liabilities of 10,276 Cr.

What is the Market Cap of Religare Enterprises Ltd?

The Market Cap of Religare Enterprises Ltd is 7,417 Cr..

What is the current Stock Price of Religare Enterprises Ltd as on 04 April 2025?

The current stock price of Religare Enterprises Ltd as on 04 April 2025 is 224.

What is the High / Low of Religare Enterprises Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Religare Enterprises Ltd stocks is ₹320/201.

What is the Stock P/E of Religare Enterprises Ltd?

The Stock P/E of Religare Enterprises Ltd is 253.

What is the Book Value of Religare Enterprises Ltd?

The Book Value of Religare Enterprises Ltd is 74.1.

What is the Dividend Yield of Religare Enterprises Ltd?

The Dividend Yield of Religare Enterprises Ltd is 0.00 %.

What is the ROCE of Religare Enterprises Ltd?

The ROCE of Religare Enterprises Ltd is 9.24 %.

What is the ROE of Religare Enterprises Ltd?

The ROE of Religare Enterprises Ltd is 5.32 %.

What is the Face Value of Religare Enterprises Ltd?

The Face Value of Religare Enterprises Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Religare Enterprises Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE